RPS Biologiques Inc. is pleased to announce the reception of two (2) Notification Numbers from the Health Canada Veterinary Drugs Directorate (VDD) for their Veterinary Health Products (VHP), Supratect-L and Supratect -P. The Notification Numbers indicate approval, allowing for marketing and sale of Supratect in Canada. The use of Supratect has been fully tested for the maintenance of optimal health of fish and fish eggs in finfish species. It consists of natural ingredients that are completely safe and beneficial for the target species. Supratect is the first and only current Natural fish health product to receive approval, in Canada, through the Veterinary Health Products notification program.
The President of RPS Biologiques, Dr. Subrata Chowdhury, says the objective of the company is to become a leader in developing safe, all natural, fish health products for use in the aquaculture sector. Dr. Chowdhury is a molecular biologist with wide experience in the fields of microbiology, virology, immunology and genetics. He notes that RPS Biologiques is continuing to develop additional, unique natural products for use in the animal health sector.
The testing undertaken to validate Supratect was completed, over a three-year period, mainly at the Huntsman Marine Science Centre located in St Andrews, New Brunswick. Established in 1969, Huntsman is a private, not-for-profit research and science based teaching institution whose work is recognized throughout Canada and internationally.
Paul Dick & Associates (PDA), a global consulting company, worked with RPS Biologiques and Health Canada to obtain notification for Supratect via the VHP program. The firm specializes in the development and registration of animal and human health products including veterinary biologics, veterinary drugs, feeds and natural health products.
RPS Biologiques Inc is a privately owned Canadian company based in Charlottetown, Prince Edward Island. A member of the PEI Bioalliance Emergence Bio-incubator.